R-MPV Regimen - CISMeF

Preferred Label : R-MPV Regimen;

NCIt synonyms : Rituximab-Methotrexate-Procarbazine-Vincristine; R-MPV; Rituximab/Methotrexate/Procarbazine/Vincristine;

NCIt related terms : R-MPV (rituximab-rixa); R-MPV (rituximab-abbs); R-MPV (rituximab-blit); R-MPV (rituximab-pvvr); R-MPV (rituximab-arrx); R-MPV (rituximab-rite); R-MPV (rituximab-rixi);

NCIt definition : A regimen consisting of rituximab, methotrexate, procarbazine and vincristine that can be used in the treatment of central nervous system (CNS) lymphoma.;

NCI Metathesaurus CUI : CL538285;

Codes from synonyms : 10999; 127919; 127762; 128547; 128704; 128076; 128233; 128390;

Détails

Origin ID

C140109;

UMLS CUI

C4682706;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Methotrexate [NCIt concept]
- Procarbazine [NCIt concept]
- Rituximab [NCIt concept]
- Vincristine [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database [NCIt concept]
- SEER Rx Interactive Antineoplastic Drugs Database-Regimen [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients